Cargando…
PHIPing along: Evolution of PHIP as a cancer biomarker and a target for therapy
Autores principales: | Kashani-Sabet, Mohammed, Bezrookove, Vladimir, de Semir, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281419/ https://www.ncbi.nlm.nih.gov/pubmed/30546826 http://dx.doi.org/10.18632/oncotarget.26341 |
Ejemplares similares
-
Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration
por: Bezrookove, Vladimir, et al.
Publicado: (2013) -
Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016) -
The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression
por: Dar, Altaf A, et al.
Publicado: (2013) -
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
por: Saqub, Hera, et al.
Publicado: (2020) -
The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
por: Dar, Altaf A., et al.
Publicado: (2015)